NIKKEI 225
39,038.16 +354.23 (+0.92%) HANG SENG
18,366.95 -109.85 (-0.59%) CRUDE OIL
77.90 +2.37 (+3.14%) GOLD FUTURES
2,329.60 +4.60 (+0.20%) DOW
38,833.51 +34.52 (+0.09%) Bitcoin GBP
54,746.42 -62.58 (-0.11%)
DXCM Nov 2024 175.000 call
| Previous close | 0.7500 |
| Open | 0.8000 |
| Bid | 0.7500 |
| Ask | 0.8500 |
| Strike | 175.00 |
| Expiry date | 2024-11-15 |
| Day's range | 0.8000 - 0.8000 |
| Contract range | N/A |
| Volume | |
| Open interest | 82 |
ZacksDexCom's (DXCM) G7 CGM System Now Connects to Apple Watch
DexCom (DXCM) announces the direct connectivity of its G7 CGM system to Apple Watch for users in the United States, the UK, and Ireland.
Business WireDexcom G7 Now Connects Directly to Apple Watch in the U.S.
SAN DIEGO, June 05, 2024--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the Dexcom G7 Continuous Glucose Monitoring (CGM) System now connects directly to Apple Watch* in the United States. Dexcom G7 is the first and only CGM available with Direct to Apple Watch, offering users the freedom and convenience of real-time glucose readings on their wrist even when their iPhone isn’t with them.†
ZacksDexCom (DXCM) Declines on Potential Competition for Stelo (revised)
DexCom (DXCM) stock declined on Monday following the FDA approval of another over-the-counter glucose monitor, potentially fueling competition for Stelo.
